You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Cytokeratin 16 antibody [EP1615Y] (ab76416)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-Cytokeratin 16 antibody [EP1615Y]
See all Cytokeratin 16 products (8) ...

Description

Rabbit monoclonal [EP1615Y] to Cytokeratin 16

Tested applications

IHC-P, WB, IP, ICC, Flow Cytmore details

Cross reactivity

Reacts with

Mouse, Rat, Human

Immunogen

A synthetic peptide corresponding to residues near the N terminus of human Cytokeratin 16

Positive control

HaCat cell lysate; human squamous cervical carcinoma tissue.

General notes

Produced under U.S. Patent No. 5,675,063.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

PBS 49%,Sodium azide 0.01%,Glycerol 50%,BSA 0.05%

Purity

Tissue culture supernatant

Clonality

Monoclonal

Clone number

EP1615Y

Isotype

IgG

  • Western blot - Cytokeratin 16 antibody [EP1615Y] (ab76416)Western blot - Cytokeratin 16 antibody [EP1615Y] (ab76416) image (enlarge)

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cytokeratin 16 antibody [EP1615Y] (ab76416)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cytokeratin 16 antibody [EP1615Y] (ab76416) image (enlarge)

  • Flow Cytometry - Cytokeratin 16 antibody [EP1615Y] (ab76416)Flow Cytometry - Cytokeratin 16 antibody [EP1615Y] (ab76416) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab76416 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

Flow Cyt: 1/50.
ICC: 1/100 - 1/250.
IHC-P: 1/100 - 1/250. Antigen retrieval is recommended before commencing with IHC staining protocol.
IP: 1/30.
WB: 1/5000 - 1/10000. Predicted molecular weight: 51 kDa.

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Tissue specificity

Expressed in the hair follicle, nail bed and in mucosal stratified squamous epithelia and, suprabasally, in oral epithelium and palmoplantar epidermis. Also found in luminal cells of sweat and mammary gland ducts.

Involvement in disease

Defects in KRT16 are a cause of pachyonychia congenita type 1 (PC1) [MIM:167200]; also known as Jadassohn-Lewandowsky syndrome. PC1 is an autosomal dominant ectodermal dysplasia characterized by hypertrophic nail dystrophy resulting in onchyogryposis (thickening and increase in curvature of the nail), palmoplantar keratoderma, follicular hyperkeratosis, and oral leukokeratosis. Hyperhidrosis of the hands and feet is usually present.
Defects in KRT16 are the cause of palmoplantar keratoderma non-epidermolytic focal (FNEPPK) [MIM:613000]. A dermatological disorder characterized by non-epidermolytic palmoplantar keratoderma limited to the pressure points on the balls of the feet, with later mild involvement on the palms. Oral, genital and follicular keratotic lesions are often present.
Defects in KRT16 are a cause of unilateral palmoplantar verrucous nevus (UPVN) [MIM:144200]. UPVN is characterized by a localized thickening of the skin in parts of the right palm and the right sole.
Note=KRT16 and KRT17 are coexpressed only in pathological situations such as metaplasias and carcinomas of the uterine cervix and in psoriasis vulgaris.

Sequence similarities

Belongs to the intermediate filament family.

Target information above from: UniProt accessionP08779 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • type I cytoskeletal 16 antibody
  • CK 16 antibody
  • CK-16 antibody
  • CK16 antibody
  • Cytokeratin-16 antibody
  • Cytokeratin16 antibody
  • Focal non epidermolytic palmoplantar keratoderma antibody
  • K 16 antibody
  • K16 antibody
  • K1C16_HUMAN antibody
  • K1CP antibody
  • Keratin 16 antibody
  • Keratin antibody
  • Keratin type I cytoskeletal 16 antibody
  • Keratin-16 antibody
  • Keratin16 antibody
  • KRT 16 antibody
  • KRT16 antibody
  • KRT16A antibody
  • NEPPK antibody
see all

Anti-Cytokeratin 16 antibody [EP1615Y] images:

  Western blot - Cytokeratin 16 antibody [EP1615Y] (ab76416)

Western blot - Cytokeratin 16 antibody [EP1615Y] (ab76416)

Anti-Cytokeratin 16 antibody [EP1615Y] (ab76416) at 1/10000 dilution + HaCat cell lysate at 10 µg

Secondary
HRP labelled goat anti-rabbit at 1/2000 dilution

Predicted band size : 51 kDa
Observed band size : 51 kDa

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cytokeratin 16 antibody [EP1615Y] (ab76416)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cytokeratin 16 antibody [EP1615Y] (ab76416)

Immunohistochemical analysis of Cytokeratin 16 in paraffin embedded human squamous cervical carcinoma tissue using ab76416 at a 1/100 dilution.

  Flow Cytometry - Cytokeratin 16 antibody [EP1615Y] (ab76416)

Flow Cytometry - Cytokeratin 16 antibody [EP1615Y] (ab76416)

Overlay histogram showing HepG2 cells stained with ab76416 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Triton X-100® for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab76416, 1/50 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit monoclonal IgG (1µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HepG2 cells fixed with 4% paraformaldehyde/permeabilized in 0.1% PBS-Triton® used under the same conditions.

References for Anti-Cytokeratin 16 antibody [EP1615Y] (ab76416)

This product has been referenced in:

  • Kästle M  et al. Combination of PDT and inhibitor treatment affects melanoma cells and spares keratinocytes. Free Radic Biol Med 50:305-12 (2011). ICC/IF, Flow Cyt; Human.Read more (PubMed: 21078385) »
  • Mardaryev AN  et al. Lhx2 differentially regulates Sox9, Tcf4 and Lgr5 in hair follicle stem cells to promote epidermal regeneration after injury. Development 138:4843-52 (2011).Read more (PubMed: 22028024) »

See all 3 publications for this product

Publishing research using ab76416? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"